Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands

Joosje H. Heimovaara*, Ingrid A. Boere, the Dutch Advisory Board for Cancer during Pregnancy, Jorine de Haan, Kristel van Calsteren, Frédéric Amant, L. van Zuylen, Christine A.R. Lok

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
38 Downloads (Pure)


BACKGROUND: Most physicians encounter pregnant women with cancer incidentally, leading to a lack of expertise or confidence to inform and treat these patients based on the most recent guidelines and expert opinions. In the Netherlands, a national multidisciplinary tumour board for cancer, infertility and pregnancy (CIP-MDT) was founded in December 2012, including 35 specialists from a variety of disciplines. This study evaluates the frequency of consultation of the CIP-MDT, the types of questions asked and the satisfaction of consulting physicians with its existence.

METHODOLOGY: Of all requests to the CIP-MDT between December 2012 and June 2021, tumour type, stage, gestational age at diagnosis and recommendations were collected and analysed. For evaluating the methods of the CIP-MDT, a survey with questions regarding experiences with the CIP-MDT and its impact on treatment decisions was sent out to physicians that consulted the CIP-MDT.

RESULTS: Recommendations (n = 213) concerned preferred and safest options for imaging, treatment options during pregnancy, possible effects on the child and fertility preserving options. Most frequently discussed malignancies were breast cancer (n = 66), cervical cancer (n = 34), haematological malignancies (n = 32) and melanoma (n = 21). The questionnaire was completed by 54% of the physicians (n = 50). Satisfaction with the recommendations of the CIP-MDT was high, and 94% of the physicians informed their patients about consulting the CIP-MDT and felt supported by the received recommendations.

DISCUSSION: The national Dutch CIP-MDT contributes to a high level of satisfaction among physicians requesting advice. Further research should be executed to confirm that a CIP-MDT improves the outcomes for pregnant women and their children.

Original languageEnglish
Pages (from-to)13-21
Number of pages9
JournalEuropean Journal of Cancer
Early online date10 Jun 2022
Publication statusPublished - Aug 2022

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Ltd


Dive into the research topics of 'Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands'. Together they form a unique fingerprint.

Cite this